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LIST OF ABBREVIATIONS 
CCT. Central conduction time. 
CM/pf. Centromedian and parafascicular nuclei of the thalamus. 
CNS. Central nervous system. 
CTX. Cerebral cortex. 
DLPFC. Dorsolateral prefrontal cortex. 
DYN. Dynorphin. 
ENK. Enkephalin. 
ERPs. Event-related potentials. 
GABA. y-aminobutyric acid. 
GLU. Glutamine. 
GPe. Globus pallidus, external part. 
GPi. Globus pallidus, internal part. 
HD. Huntington's disease. 
HDC. Asymptomatic carriers of the CAG repeat extension-
MSN. Medium spiny neurons. 
PCL. Probabilistic classification learning. 
PD. Parkinson's disease. 
SEPs. Somatosensory evoked potentials. 
SMA. Supplementary motor area. 
SNc. Substantia nigra, pars compacta. 
SNr. Substantia nigra, pars reticulata. 
SP. Substance P. 
STN. Subthalamic nucleus. 
TH. Thalamus. 
VA. Ventral-anterior. 
VL. Ventral-lateral. 
WCST. Wisconsin Card Sorting Test. 
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SUMMARY 
The basal ganglia are large subcortical nuclear masses that are interconnected with all 
cortical areas, and that receive updating (via thalamus) from most of the pathways leaving and 
targeting the cortex. This strategic position enables the basal ganglia to play a leading role in 
the synchronization of a wide range of central nervous system (CNS) functions. In an attempt 
to further elucidate the importance of these structures, we investigated the consequences of 
basal ganglia dysfunction (especially those of the striatum) at three levels of integration: 
primary perception, perceptual categorization/decision process and cognitive functions. 
We addressed the changes in primary perception and cortical excitability using 
somatosensory evoked potentials (SEPs). Perceptual categorization and decision-making was 
assessed by means of event-related potentials (ERPs) based on a visual categorization task. 
Cognitive impairment was investigated using a battery of tests with special emphasis on 
attentional set-shifting and habit-learning. 
As models for basal ganglia dysfunction (and specifically striatal damage), we 
included Huntington's disease (HD) patients, their symptom-free relatives at risk (carrying the 
genetic mutation, a CAG trinucleotide expansion) and a patient with focal vascular lesions of 
the right striatum. 
SEPs and ERPs revealed diminished cortical amplitudes in HD and in focal lesions of 
the striatum, which indicates that cortical excitability is decreased when striatum is damaged. 
The amplitude reduction of the median nerve SEPs in HD was proportional to the extent of 
the genetic mutation i.e. the length of the trinucleotide repeat. It is the first time one could 
establish a correlation between the magnitude of a trinucleotide expansion and the extent of 
the neurophysiological consequence. Tibial nerve SEPs proved to be a sensitive method for 
detection of early pathophysiological changes in HD, in our study being the only 
neurophysiological alteration in asymptomatic carriers of the mutation. Focal lesions of the 
striatum differentially affected the cortical components of the median nerve SEPs, with more 
severe impairment of the frontal than the parietal components. 
Perceptual categorization/decision process showed a specific pattern of alteration in 
HD, according to the ERPs. The category-specificity of a negative wave starting at 150 ms 
post-stimulus was impaired at the temporal recording sites. These data further emphasize the 
5 
importance of striato-temporal circuits in the visual categorization/decision process. Since this 
pattern of alteration is different from both patients with Parkinson's disease and focal vascular 
lesions, our results demonstrate that different basal ganglia pathologies have distinct 
neurophysiological consequences. 
Focal lesions of the striatum caused a significant impairment in habit learning. This is 
in consistence with data from HD patients, concerning the involvement of the striatum in this 
cognitive function. We also proved that attentional set-shifting (executive dysfunction) is 
independent from habit learning problems. 
Taken together, our data suggest that striatum plays a crucial role in the organisation 
of such distinct CNS functions as primary perception, perceptual categorisation/decision and 
habit learning. Thus clinical consequences of striatal damage must be thought off as a 
summation of these multilevel malfunctions. 
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VIII. 
INTRODUCTION 
1. ANATOMY OF THE BASAL GANGLIA 
There is still a debate on the number of structures that are part of the basal ganglia. The 
main components are five nuclei: the caudate nucleus (with the adjacent nucleus accumbens), 
putamen, the subthalamic nucleus, substantia nigra and the globus pallidus. However, based 
on the tight functional connections, some authors refer to the central complex of the thalamus, 
amygdala and hippocampus as parts of the basal ganglia (Herrero et al. 2002, Obeso et al. 
2002, Ring and Serra-Mestres 2002, Yelnik 2002). 
The caudate nucleus (consisting of head, body and tail) and the putamen form together 
the striatum. The putamen and globus pallidus are described as the lentiform nucleus. These 
structures are situated deep in the hemispheres, lateral to the thalamus and lateral ventricles. 
Globus pallidus (forming the medial part of the lentiform nucleus) is subdivided into an 
external (GPe) and an internal (GPi) part. Substantia nigra, situated in the rostral part of the 
midbrain, next to the cerebral peduncles, comprises two major subdivisions: the pars 
compacta (SNc) that is rich in dopaminergic cells and the pars reticulata (SNr). The 
subthalamic nucleus (STN) has the shape of a biconvex lens and is situated between the 
thalamus and the substantia nigra. 
Recently an additional term, "ventral striatum" has been introduced to describe the 
parts of the basal ganglia closest to the limbic system and that are involved in cognitive and 
behavioral functions. These are the nucleus accumbens (located on the ventromedial side of 
the head of the caudate nucleus) and the ventral part of the caudate/putamen (Alheid et al. 
1990). Within the ventral striatum one can differentiate the core and the shell. The later has a 
rich dopaminergic innervation arising from the ventral tegmental area and dense innervation 
from the basolateral complex of the amygdala (Everitt 1999). 
Striatal neurons are mainly (96%) inhibitory GABA-ergic neurons, whose dendrites 
are covered with dendritic spine ("medium spiny neurons, MSN"). Their axon gives dense 
local collateral arborization to other medium spiny neurons. These cells express enkephalin or 
substance P and dynorphin. The remaining 4% are interneurons: large, aspiny cholinergic 
neurons that are involved in learning reward behavior, and small GABA-ergic interneurons 
that contribute to the surrounding inhibition. In contrast, the pallidal and nigral neurons have 
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long, thick, smooth and sparsely branched dendrites. They are GABA-ergic too. The neurons 
of the subthalamic nucleus are glutamatergic ones. Their dendrites are intermediate between 
the striatal and the pallidal features (Yelnik 2002). 
Neurons in the striatum are organized into patches, defined by their cortical 
afferentation and expression of neurotransmitters and neuropeptides. The smaller of these 
compartments are called striosomes that connect to limbic structures. These are embedded in 
a larger compartment called the matrix, that is thought to mediate information critical for 
motor and cognitive behavior (Côté and Crutcher 1991). 
2. PHYSIOLOGY OF THE BASAL GANGLIA 
The subcortical connection loops (cortex-basal ganglia-thalamus-cortical circuits) 
constitute the basis for basal ganglia functioning in the CNS (Côté and Crutcher 1991, Obeso 
et al. 2002, Nakano 2000, Parent A 2001, Yelnik 2002). 
FIGURE 1. CONNECTIONS OF THE BASAL GANGLIA 
(See list of abbreviations.) 
The major input structure of the basal ganglia is the striatum (figure 1). Most of the 
information comes from the cortex. The ventral striatum receives a prominent projection from 
the amygdala. The striatum is also a major target of the dopaminergic neurons from SNc. 
The major output structures of the basal ganglia are the GPi and the SNr. Via the 
anterior and lateral nuclei of the thalamus the pallidal output is then transferred to the frontal 
cortex, supplementary motor area (SMA), while the nigral output is directed mainly to the 
dorsolateral prefrontal cortex. Globus pallidus and STN receive dopaminergic inputs too, but 
to a lesser degree than the striatum (figure 1). 
The volume of the striatum is 20 times larger than that of the GPi and SNr (Yelnik 
2002). This dramatic decrease suggests an important convergence of information between the 
input and the output structures. 
There are (at least) two different ways, the input and output structures of the basal 
ganglia connect (figure 2). The direct pathway (stratum-GPi/SNr) has an excitatory effect on 
the thalamic neurons and, on turn, to the cortex (Albin et al. 1989). The indirect pathway 
(striatum-GPe-STN-GPi/SNr) has an inhibitory final outcome. Striatal neurons that express 
supstance P and endorphyn are thought to be part of the direct pathway, and to receive 
excitatory dopaminergic inputs (D1 receptors). In contrary, MSN that take part in the 
formation of the indirect pathway are expressing enkephalin and receive inhibitory 
dopaminergic inputs (D2 receptors). This model can explain why the loss of nigrostriatal 
neurons in Parkinson's disease (PD) leads to a pauperization of movement pattern (decreased 
activity in the excitatory-direct pathway, and decreased activity in the inhibitory-indirect 
pathways). 
Recently, a "hyperdirect" cortico-subthalamo-pallidal pathway was described, that 
bypasses the striatum (Nambu et al. 2002). It was hypothesized that at the beginning of a 
movement initiation, this pathway inhibits large areas of the thalamus and cortex that are 
related to both the selected motor program and other competing programs. Then another 
signal, disinhibits the selected program through the direct pathway. Finally, impulses through 
the (inhibitory) indirect pathway terminates the action. 
Initially only two parallel subcortical loops were suggested: a motor loop passing 
through the putamen and an association ("complex") loop passing through the caudate. 
Subsequently five parallel circuits were identified: motor, oculomotor, dorsolateral 
prefrontal, lateral orbitoffontal and limbic / anterior cingulate circuits (Alexander et al. 1986). 
However the complexity of the connections is much higher. 
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In addition to these "external" loops, there are several "internal" circuits, 
interconnecting subcortical nuclei. Most of these are thalamo-basal ganglia-thalamic "closed" 
loops: centromedian / parafascicular thalamic nuclei (CM/pf)-striatum-GPi-CM/pf (positive 
feedback loop), CM/pf-striatum-STN-GPi-CM/pf (negative loop) (Obeso et al. 2002). 
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FIGURE 2. DIRECT AND INDIRECT PATHWAYS 
Excitatory neurotransmitters are indicated in green, while inhibitory ones in red color. Also 
see list of abbreviations. 
Today, the basal ganglia system is subdivided in three functional territories (i.e. group 
of circuits, rather than circuits). These are: the sensory-motor territory (putamen) projecting 
back to motor cortices (primary motor cortex, SMA, premotor cortex), the associative 
territory (dorsal caudate nucleus) projecting to the prefrontal cortex, and the limbic territory 
(ventral striatum) projecting to the anterior cingulate cortex and medial orbitofrontal cortices. 
There is considerable cross talk between these parallel circuits, making possible a higher level 
of integration between different CNS functions (Yelnik 2002). 
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Thus, basal ganglia play a crucial role in the coordination of a wide spectrum of CNS 
functions ranging from sensory and motor integration to cognitive and affective functions. 
Recording impulse activity of neurons in the basal ganglia shed light on the possible 
mechanisms employed by the basal ganglia in achieving this goal (Kropotov and Etlinger 
1999). The basal ganglia-thalamocortical circuits become active only when a stimulus is 
attended or when a movement is voluntarily implemented. Thus they are involved in the 
process of selection of an appropriate sensory stimulus and in the selection of an appropriate 
motor action. This is realized by inhibitory, opponent neuronal mechanisms, suppressing 
inappropriate actions and initiating the selected one, in a "winner takes all" manner. 
3. NEUROPSYCHIATRY OF THE BASAL GANGLIA 
Considering the anatomy and physiology of the basal ganglia, it is not surprising, that its 
damage leads to many neurological and psychiatric diseases, and their presentation exceeds 
the limits of this thesis (for a review see: Ring and Serra-Mestres 2002). 
The "classic" basal ganglia disorders are PD and related symptoms (progressive 
supranuclear palsy, multisystem atrophy), HD, Wilson's disease (copper deposition in the 
lentiform nucleus), Fahr's disease (calcium deposition in the basal ganglia), Gilles de la 
Tourette's syndrome (a combination of multiple motor and vocal tics). 
However, there is mounting evidence that in many other diseases, malfunctioning of 
the basal ganglia is an important or possibly even the most important aspect: obsessive-
compulsive disorder, depression, schizophrenia, addiction, attention-deficit hyperactivity 
disorder. 
4. HUNTINGTON'S DISEASE 
HD is a neurodegenerative disorder with autosomal dominant inheritance, characterized 
by choreoathetotic movement abnormalities, and cognitive and emotional impairment (Ross 
and Margolis 2001). The pathology of HD consists in atrophy in selective areas of the brain, 
the earliest and most severe neuronal loss affecting the MSN in the striatum. 
The HD gene has been shown to be an expanded (>38) triplet repeat (CAG) sequence 
on chromosome 4, with longer repeats yielding an earlier age of onset (Group HDCR 1993, 
Duyano et al. 1993). Postmortem examination demonstrated a strong correlation between the 
extent of neuronal loss in the striatum and the number of nucleotide repeats (Furtado et al, 
1996). 
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5. FOCAL LESIONS OF THE BASAL GANGLIA 
There is much to be learned from humans whose brains are damaged by insults restricted 
to single anatomical structures. Because such lesions are rare, many reports of 
clinicopathological correlation are based on single cases or small series of patients. Bhathia 
and Marsden performed a meta-analysis of these papers, collecting 240 patients divided in 
two groups: those with small lesions only involving the basal ganglia and a group with larger 
lesions with additional involvement of the adjacent structures (Bhathia and Marsden, 1994). 
This comprehensive study revealed that isolated lesions of the basal ganglia (most of them 
vascular in origin) cause a wide variety of symptoms, from involuntary movements to acute 
confusion and aphasia. Lesions of the caudate nucleus most frequently cause behavioral or 
cognitive symptoms (abulia, disinhibition), while lesions of the lentiform nucleus 
predominantly cause dystonia. 
6. SOMATOSENSORY EVOKED POTENTIALS IN BASAL GANGLIA DISEASES 
SEPs are non-invasive, neurophysiological methods that make possible to record in 
different parts of the nervous system the electric activity evoked by stimulation of peripheral 
nerves (Osselton 1995). 
Abnormalities of SEPs in HD patients were first described by Takahashi and Okada in 
1972. All later studies revealed a drastic decrease in amplitude of the early cortical response 
to median nerve stimulation in spite of the differences in the methods and in the way the 
cortical components were defined (Oepen 1981, Jossiasen 1982, Ehle 1984, Noth 1984, 
Bollen 1985, Abbruzzese 1990, Yamada 1991, Topper 1993). Conflicting results have been 
reported as concerns the latency and central conduction time (CCT): some authors observed a 
slowing of conduction (Takahashi and Okada 1972, Oepen 1981, Josiassen 1982, Abbruzzese 
1990), while others noted normal values (Ehle, 1984, Bollen 1985, Yamada 1991, Topper 
1993). Though less extensively studied, a reduction in the amplitude of the early cortical 
components of the tibial nerve SEPs has also been reported (Noth 1984, Bollen 1985). 
Since HD is not commonly associated with sensory symptoms, there is considerable 
controversy as to the cause of these well-documented neurophysiological changes. It was 
previously shown that the extent of striatal degeneration is proportional to the length of CAG 
expansion. Thus, we have approached the issue of striatal involvement in SEPs amplitude-
decrease by determining the relationship between the severity of SEP changes and the length 
of the triplet repeat sequence in HD patients and their relatives at risk. 
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There is still much controversy about the SEPs alteration in PD. Several authors found 
a significantly reduced frontal N30, in spite of normal parietal components in PD patients 
(Rossini 1989, 1991, Onofrj 1995, Bostantjopoulou 2000). Since the frontal cortex receives a 
major input from the basal ganglia via the thalamic nuclei, it was hypothesized that a 
reduction in the N30 might be the consequence of an impairment of these inputs. However 
other authors could not replicate these findings (Mauguiere 1993, Garcia 1995, Drory 1998) 
and even the origin (or origins) of N30 is not clear. 
There are only few reports concerning N30 in focal intracerebral lesions, and none of 
them affecting the basal ganglia. Rossini et al. reported the selective elimination of the N30 
on the side, where a meningioma was compressing the SMA (Rossini 1989). Selective loss of 
the frontal N30 component was also reported in 2 patients with precentral cortical lesions 
(Mauguiere 1983) and three patients with focal capsular vascular lesions selectively 
deafferenting the prerolandic cortex (Mauguiere 1991). 
To investigate the suggested role of the basal ganglia in the generation of the N30 
component, we recorded the median nerve SEPs in a patient with focal vascular lesion 
affecting only the striatum in one hemisphere. 
7. EVENT RELATED POTENTIALS IN BASAL GANGLIA DISEASES 
In 1996 Thorpe et al., recording event-related potentials (ERPs) during a visual 
categorization task, showed that a frontal negativity, at 150 ms after stimulus presentation 
(N150) was specific to the stimulus-category. The subjects had to decide, whether a 
photograph, flashed on for just 20 ms contained or not an animal. The category-specific N150 
was thought to be the neurophysiological correlate of perceptual categorization and 
subsequent decisional processes. 
Using a similar categorization-task ERPs (animal versus non-animal images) previous 
studies have shown specific alterations in PD patients. While in healthy subjects the evoked 
negativity at 150 ms post-stimulus presentation (N150) was higher for non-animal, than for 
animal images, this difference was abolished at all electrode sites for PD patients (Antal 2002 
a, 2002 b). Because the degenerative process in PD is not confined to the nigrostriatal 
pathways but involve several other structures (dorsal raphe nuclei, locus coeruleus, nucleus 
basalis of Meynert), the N150 alteration might not solely reflect striatal pathology. Since these 
structures are unaffected in HD, it was tempting to use the same categorization-task ERPs in 
HD patients and their relatives at risk to check the role of the striatum in the 
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categorization/decision process. In addition, we performed the same categorization-task ERPs 
on a patient with vascular lesions of the right striatum. 
In HD most of the previously published visual neurophysiological investigations 
focused on the characteristics of the ("classic") P300 component of the ERPs, which is 
thought to reflect the attentional allocation and working memory updating. They have 
generally revealed amplitude reduction and disorganization of the components with or without 
latency shifts (Rosenberg 1985, Homberg 1986, Munte 1997). 
8. COGNITIVE DYSFUNCTION IN BASAL GANGLIA DISEASES 
Cognitive impairment is a prominent feature of the pathologies affecting the basal ganglia 
(Ring and Serra-Mestres 2002). In PD patients, the most common problems are the slowing of 
mental processing (bradyphrenia), altered executive function as well as memory, and are in 
keeping with a subcortical pattern of dysfunction caused by disruption of frontosubcortical 
circuits and dopaminergic deficit in the mesocortical pathways. In HD, cognitive impairment 
is present early in the course of the disease. Slowing of cognition and difficulties with mental 
flexibility appear soon after the onset. Altered verbal fluency is one of the earliest cognitive 
deficits. Later on, cognitive impairment gradually worsens to a dementia of frontosubcortical 
pattern. 
Adaptive behaviour requires the learning of stimulus-reward associations and 
the flexible shifting of response strategies. These functions are integrated in a widely used 
neuropsychological procedure, the Wisconsin Card Sorting Test (WCST) (Heaton et al. 
1993). In the WCST, subjects are asked to sort test cards to one of four key cards that vary in 
shape, colour, and number. From the three perceptual dimensions, only one can be used for 
sorting (e.g. test cards should be matched to the key card with identical colour). Participants 
receive feedback to ascertain the categorisation rule, which shifts after a predefined number of 
successful decisions (e.g. from colour to shape). It has been demonstrated that patients with 
lesions to the dorsolateral prefrontal cortex (DLPFC) are less able to shift the sorting strategy 
(perseverative errors). However functional imaging studies showed that many other structures 
(including the caudate nucleus), besides DLPFC are activated during the test (Berman et al. 
1995, Nagahama et al. 1996, Konishi et al. 1998, 1999). Early-stage HD patients were 
impaired in shifting cognitive set (Jossiassen et al. 1983). 
The WCST can be decomposed into several domains with potentially separate 
cognitive and neuronal mechanisms. These can be systematically investigated using a 
multistage visual discrimination learning / attentional set-shifting paradigm (Downess et al. 
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1989). This task includes a series of two-alternative forced-choice visual discriminations. In 
the first stages, the discrimination of a simple stimulus pair and its reversal are requested. 
After an intradimensional shift phase (shift to another feature within the same perceptual 
dimension) subjects must adopt a new strategy by responding according to a previously 
ignored perceptual dimension. This extradimensional shift phase is believed to be the 
equivalent of the category-shift in the WCST. PD patients had difficulty throughout the task, 
while early stage HD patients showed a striking impairment specifically at the 
extradimensional shift phase (Downess et al. 1989, Owen et al. 1993, Lawrence et al. 1998). 
Recently, the probabilistic classification learning (PCL) test has been introduced as a 
tool for investigating the parallel memory systems, including non-declarative learning 
functions related to the basal ganglia (Knowlton et al. 1996). In the PCL, subjects have to 
classify stimuli consisting of geometric shapes (cues) into two categories. Each cue is 
probabilistically related to one of the two categories. For example, the presence of cue A 
indicates that the stimulus belongs to the first category with a high probability, while cue B 
predicts the opposite category-membership. The probabilistic structure defeats the conscious 
memorisation of solutions. Some authors consider PCL a characteristic of striatally mediated, 
non-declarative, habit-based (i.e. stimulus-response reinforced) learning (Knowlton et al. 
1996, Robins 1996). It has been shown that the PCL can be solved even if hippocampus and 
DLPFC are damaged, but not when basal ganglia functions are impaired: PD and HD patients 
showed marked abnormalities in the PCL task (Knowlton et al. 1994, 1996, Lawrence et al. 
1998, Kéri et al. 2002). This suggests that the hippocampal/diencephalic explicit memory 
system and the DLPFC are dispensable for habit learning. Evidence from a recent, functional 
magnetic resonance imaging (fMRI) study supports this view. During the PCL task, increased 
blood-flow was detected in the bilateral frontal, occipital, and striatal regions, while the 
hippocampus was less active (Poldrack et al. 1999). It is noteworthy that striatal structures 
were active in both reversal learning and PCL paradigms, which supports the hypothesis that 
these stimulus-reward learning procedures share similar neuronal mechanisms. 
Although nigral and striatal structures bear the brunt of the pathology in PD and HD 
respectively, the degenarative processes are not limited to these basal ganglia structures. Thus, 
it seemed intriguing to investigate these cognitive impairments in a patient with focal lesions 
confined to the right striatum. 
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VIII. 
MATERIAL AND METHODS 
1. SUBJECTS 
Eleven patients with manifest HD showing typical cognitive and motor symptoms and six 
asymptomatic relatives were investigated. All of these subjects had a pathologic extension of 
the CAG repeat (shown by polymerase chain reaction) and no history of diabetes, alcoholism 
or mental deterioration (other than HD). The Ethics Committee of Szeged University Health 
Science Center approved the studies. All the subjects gave their informed consent, in 
accordance with the Declaration of Helsinki. Four patients were receiving tiapride and 1 
patient was receiving haloperidol medication at the time of testing. The control group was 
recruited from the university staff and their relatives. None of the control subjects had 
neurological signs or symptoms and none of them was taking CNS-active medication. SEPs 
were recorded in 16 subjects displaying an extension of the CAG repeat (11 patients with 
manifest HD, 5 asymptomatic carriers) and 20 healthy controls. The ages of the HD patients 
varied between 21 and 80 years (mean = 48.45), the mean duration of the illness was 8.27 
years (range: 1-17) and the median number of CAG trinucleotide was 45 (range 40-70). The 
mean age of the asymptomatic carriers (HDC) was 34.40 years (range: 27-44) and the median 
number of CAG trinucleotide was 44 (range 41-46). The mean age of the healthy control 
subjects was 37.20 years (range: 19-61). ERPs were recorded in 15 subjects with CAG 
expansion (9 HD patients, 6 asymptomatic carriers) and 14 healthy controls. They all fulfilled 
the following criteria: clear ocular media, normal intraocular pressure, and visual acuity better 
than 0.9 with or without correction. The age of HD patients (7 males, 2 females) was in the 
range of 28-60 years (mean = 48.66), the mean duration of the illness was 7.87 years (range: 
1-14), the median number of the CAG trinucleotides was .45 (range: 40-51). The age of the 
HDC subjects (4 males, 2 females) was in the age range of 27-52 years (mean = 37.83) and 
the median number of CAG trinucleotide was 43 (range41-46). The mean age of the healthy 
controls was 44.2 years (range: 30-60). The mean score in the Mini-Mental State Examination 
(MMSE) was 22.7 (range: 18-24) in the HC group, 29.2 (range: 28-30) in the HDC group and 
29.6 (range: 28-30) in the control group. There were no significant differences between the 
control and HD, HDC subjects concerning their age and education level (p>0.05). 
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In addition, we investigated a patient (ST) suffering form a rare form of cerebral vasculitis 
(granulomatous angiitis), proven by neuroimaging and laboratory data. ST was a 22-year-old 
right-handed Caucasian man (education: 12 years, WAIS-IQ: 106). Head MRI revealed that in 
the right hemisphere the lesions were confined to the striatum: head of the caudate nucleus 
(figure 3, bold arrow), anterior part of the putamen (figure 3, arrow). In the left hemisphere, 
there was a small lesion in the medial part of the thalamus and three small lacunar cortical 
infarcts (pre- and postcentral gyri, superior parietal lobe). Tests were performed before and 
after the steroid therapy. 
FIGURE 3. FOCAL LESIONS OF THE RIGHT STRIATUM 
For the cognitive tests we used two control groups: one with parietal lesions and one of 
healthy volunteers. The control group with parietal lesions included three patients (mean age: 
37.7 years (SD=25.5), mean years of education: 9.7 (SD=1.5), mean WAIS-IQ: 97.3). Two 
patients had bilateral parietal atrophy extending to the inferior and superior parts, and one 
patient had ischemic infarcts in the left parietal lobe, including the postcentral gyrus. One 
patient received anticonvulsant treatment (carbamazepine, 400 mg/day), and one patient 
17 
exhibited psychotic symptoms two years before the testing. The latter participant received 
combined antidepressant (citalopram, 20 mg/day) and antipsychotic (olanzapine, 15 mg/day) 
medication at the time of testing. The healthy control group comprised ten male volunteers 
without any history of neurological or psychiatric disorders (mean age: 21.9 years (SD=1.6), 
mean years of education: 10.3 (SD=1.8), mean WAIS-IQ: 103.9 (SD=5.9)). 
2. SOMATOSENSORY EVOKED POTENTIALS (SEPs) 
The subjects were lying supine, in a quiet, semi-darkened room. Square wave electrical 
pulses of 0.2-msec duration were applied at a stimulus frequency of 4 Hz to the median nerve 
at the wrist and subsequently to the posterior tibial nerve at the ankle. By means of unilateral 
stimulation, the left and the right sides were examined separately. The current intensity was 
adjusted so as to produce a visible twitching of the short muscles of the thumb or of the 
abductor hallucis after stimulation of the median nerve or of the tibial nerve, respectively. 
The recording electrodes were placed at the posterior midline of the neck at C7 level (with 
an anterior cervical reference placed above the process of the thyroid cartilage) and on the 
scalp, over the contralateral hand field (2 cm posterior and 1 cm lateral to C3 and C4, 
according to the 10-20 International system) for the median nerve and 2 cm behind Cz for the 
tibial nerve. For all scalp recordings, an ipsilateral earlobe reference was used. The impedance 
was less than 5 kQ. The signals were fed into amplifiers (Nihon Kohden Neuropack) and 
bandpass-filtered (5-3000 Hz). The sweep time was 100 msec. 1000 sweeps were averaged 
and at all stimulation sites the measurement was repeated once to check the reliability of the 
curves. Samples contaminated by artifacts such as movement or muscle potentials were 
effectively rejected by auto-rejection mode. 
Peaks were identified with a cursor on the computer display. CCT was determined for the 
median nerve SEP as the difference between the peak latencies of parietal N20 and cervical 
N13, and for the tibial nerve SEP as the difference between those of cortical P40 and lumbar 
N22. We determined CCT because the three groups were not height-matched and CCT is 
unrelated to the height of the subjects. Peak-to-peak amplitudes for the median nerve at the 
frontal channel (P20-N30), at the parietal channel (P14-N20) and for the tibial nerve (P40-
N50 and N50-P60) were determined. 
3. EVENT-RELATED POTENTIALS (ERPs) 
The stimulus battery included approximately 1000 color photographs of complex natural 
images, containing either an animal or a non-animal item (figure 4). All stimuli were available 
from commercial databases and were matched for average luminance. All stimuli subtended a 
vertical visual angle of 10° and a horizontal visual angle of 15° from a viewing distance of 1 
m. A small fixation dot was present in the middle of the video screen (Studioworks 57i), 
controlled by an IBM Pentium PC. The luminance of the stimulus area (80 cd/m2) and the 
background luminance (8 cd/m ) were held constant throughout the experiment. 
Participants were asked to fixate the small dot in the middle of the screen. The subject 
with pressing one of the two response buttons initiated the sequence of trials. One trial 
consisted of the presentation of a single stimulus for 26 ms. Subjects were asked to decide 
whether the presented image contained an animal (target) or a non-animal (distracter) item 
with pressing the appropriate button within 1500 ms (figure 4). The interstimulus interval was 
2 s. Stimuli were presented in a randomized order. The probability of target and distracter 
items were equal (50%). The task consisted of 500 trials in two separate blocks of 250 trials. 
No images were presented twice in order to avoid practice effects. A training block was given 
before the test to ensure that each subject understood the task. None of the subjects reported 
any fatigue effect after the presentation of the two blocks. 
FIGURE 4. SCHEMATIC REPRESENTATION OF THE ANIMAL/NON-ANIMAL 
VISUAL CATEGORIZATION-TASK ERPs 
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For the neurophysiological recordings, gold cup electrodes with a diameter of 6 mm 
were used, which were placed in accordance with the international 10-20 system. The primary 
evoked potential was recorded at Oz referred to an electrode positioned at 70% of the distance 
between inion and nasion. ERPs were recorded at Fz, Cz, Pz, F3, F4, T3, and T4 referred to 
linked mastoids (Rim). The ground electrode was located on the forehead. Signals were 
amplified 10,000 times. Data were collected and analyzed off-line by an IBM-compatible PC. 
Filters were set at 0.1 and 70 Hz. A notch filter was used to remove 50 Hz interference. The 
sampling rate was 1,000 Hz. Individual potentials were baseline corrected on the basis of a 
100 ms prestimulus period. The analysis time of poststimulus period was 500 ms. In order to 
control eye movements, a concurrent electrooculogram (EOG) was recorded. Automatic 
artifact rejection was used to remove trials with amplitude higher than 50 pV. 
Mean amplitudes were measured between 150 and 250 ms (N150) following stimulus 
onset. To test the normality of distribution, data were entered into Kolgomorov-Smirnov 
analyses. Mean amplitudes were analyzed with 3 (group: controls vs. HD patients vs. HDC 
subjects) x 2 (stimulus: target vs. distracter) x 7 (electrode sites) repeated measures analyses 
of variances (ANOVAs). For post-hoc comparisons, Fisher's LSD tests were used. To control 
type II errors, Greenhouse-Geisser corrections were included. 
4. COGNITIVE TESTS 
Besides the IQ (Wechsler, 1981), the neuropsychological evaluation included the 
following tests: (1) WCST (attentional set-shifting), (2) PCL (habit learning and episodic 
memory), (3) digit span forward and backward (working memory), (4) word span and 
alphabet span (working memory), (5) phonological and semantic fluency (verbal initiation 
and generation), (6) Benton Facial Recognition Test and Object Decisions (visual perception), 
(7) Association Match and Category Match (semantic memory). The first five tests were 
administered before and after the steroid therapy. The time interval between the pre- and post-
treatment assessments was one month. Similarly, these tests were repeated in the healthy 
control subjects after one month of initial assessment. 
WCST. The procedure is described in details elsewhere (Heaton et al. 1993). Briefly: 
subjects are asked to sort test cards to one of four key cards that vary in shape, colour, and 
number (figure 5). From the three perceptual dimensions, only one can be used for sorting 
(e.g. test cards should be matched to the key card with identical colour). Participants receive 
feedback to ascertain the categorisation rule, which shifts after a predefined number of 
successful decisions (e.g. from colour to shape). The number of categories completed and the 
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number of perseverative errors were the dependent measures. 
A B C 
color 
\ 1 
shape 
test card 
FIGURE 5. WISCONSIN CARD SORTING TEST (WCST) 
PCL. To assess the functioning of the striatal habit learning system, the PCL paradigm 
was used. In the weather prediction task (figure 6), which was a pen-and-paper version of the 
original version (Knowlton et al, 1994, 1996, Kéri et al. 2002), the participant was asked to 
decide whether a pattern of cues predicted category 1 (rain) or category 2 (sunshine). In each 
set, cues (simple geometric shapes) were included. Each cue was associated with a particular 
category with a certain probability (figure 6). In each trial 1, 2, or 3 cues were presented. The 
cues were printed on cards and their left-to-right sequence was randomised. The participant 
was asked to decide whether the cue(s) indicated rain or sunshine. The decision time was 
limited to 5 sec. If no response was made, the subject was asked again to categorise the 
stimulus. After each trial (response), the examiner provided verbal feedback (stating whether 
the cue represented rain or sunshine). Altogether, 100 trials were included (10 blocks of 10 
trials). In the case of ST, the test was repeated four times with different sets before and four 
times after the therapy. In the case of each patient with parietal lesions, the test was repeated 
with two different sets. Data from normal control participants showed that equal learning 
effects could be obtained using the different sets. Performance was defined as the percentage 
of correct responses. Cue patterns associated with rain and sunshine with equal probabilities 
were excluded from the data analysis. 
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FIGURE 6. PROBABILISTIC CLASSIFICATION LEARNING 
"Napsütés" is the Hungarian for sunshine, which is one of the two categories in the task. 
Explicit episodic memory for the habit learning task was assessed with a multiple-choice 
task, including questions about the cues, the layout of experimental environment, and the 
training episode (chance level: 25%). 
Digit span forward and backward. In the digit span forward test of the WAIS 
(Wechsler, 1981), increasingly longer strings of numbers are recalled (1-9 letters). In the 
backward version, subjects repeat the numbers in reverse order. Span length is defined as the 
numbers of digits recalled correctly before two strings of the same length were failed. 
Word span forward and alphabet span. In the word span test, increasingly longer 
strings of one syllable, high-frequency words are recalled (2 to 8 words) (Paivio et al. 1968). 
In the alphabet span task, words are recalled in alphabetical order (Craik, 1986). The length of 
word strings was calculated in the same manner as in the digit span task. 
Phonological and semantic fluency. For the assessment of phonological fluency, the 
Controlled Oral Word Association Test was used (Benton and Hamsher 1976). In this test, 
subjects are asked to retrieve as many words as possible beginning with letters F, A, and S for 
1 min each. Participants were requested to avoid proper names and places. The dependent 
measure was the mean number or words generated over 1 min ([F + A + S] / 3). Errors were 
excluded. In the assessment of semantic fluency, the task was to generate words belonging in 
the category of animals and furniture for 1 min each (Randolph et al. 1993). The dependent 
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measure was the mean number or words generated ([category A + category B] / 2). Errors 
(repetitions and words outside the categories) were excluded. 
Benton Facial Recognition Test and Object Decisions. These tests were designed to 
investigate visual perception. In the Benton Facial Recognition Test, subjects are required to 
match faces shown under different angles and different shadowing (Lezak 1995). In the 
Object Decision test, pairs of pictures of the same objects are presented that are differing only 
in one detail (e.g. a bear with rounded or pointed ears) (Goldenberg and Karlbauer 1998). 
Association Match and Category Match. These tests were designed to investigate 
semantic memory. In the Association Match of the Pyramids and Palm Tree Test, a target 
picture is shown with two choice pictures. One of the choice pictures is functionally 
associated with the target picture (Howard and Patterson 1992). In the Category Match 
version, choice pictures must be matched by superordinate category rather than by functional 
associations (Goldenberg and Karlbauer 1998). 
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IV. 
RESULTS 
1. PRIMARY PERCEPTION AND CORTICAL EXCITABILITY (SEPs) 
SEP amplitudes and CCT in HD and HDC 
Initial analyses of variance (ANOVAs) and Mann-Whitney U tests revealed no 
significant difference between the median and tibial nerve SEP data obtained from the left-
and right-sided recordings (p>0.6). Similarly, there was no laterality-specific difference 
between any of the three experimental groups (p>0.7). Therefore, the SEP data from both 
sides were averaged for further between-group comparisons. 
Table 1 shows median and tibial nerve SEP parameters for the HD patients, the HDC 
subjects and the healthy control subjects. Figure 7 shows SEP recordings on a control subject 
and on a HD patient 
HD 
(n=l l ) 
HDC 
(n=5) 
Controls 
(n=20) 
t score 
(HD vs. 
controls) 
P 
(HD vs. 
controls) 
t score 
(HDC vs. 
Controls) 
P 
(HDC vs. 
controls) 
CCT 
N13-N20 
5.94 
(1.13) 
6.21 
(0.64) 
5.64 
(0.65) 
-1.28 0.2074 -2.37 0.0218 
P14-N20 
amplitude 
1.53 
(1.69) 
2.26 
(1.01) 
3.06 
(1.69) 
4.57 0.00003 2.36 0.0223 
P20-N30 
Amplitude 
0.91 
(1.01) 
1.56 
(0.86) 
2.08 
(1.02) 
4.36 0.00005 1.49 0.1423 
CCT* 
N22-P40 
- 16.41 
(1.67) 
18.15 
(15.20) 
- - 0.33 0.7358 
P40-N50 
amplitude 
0.19 
(0.48) 
1.33 
(0.76) 
2.67 
(1.44) 
7.82 <0.00001 2.84 0.0065 
N50-P60 
Amplitude 
0.19 
(0.45) 
1.44 
(0.65) 
3.05 
(1.66) 
7.88 <0.00001 3.00 0.0043 
Table 1. 
Mean (SD) central conduction time (CCT) (msec) and peak-to-peak amplitude (pV) of the 
median and tibial nerve SEP cortical components in the patients with Huntington's disease 
(HD), the asymptomatic mutation carriers (HDC) and the healthy control subjects. 
*The mean CCT is not indicated for the HD group, because most of the patients (n=9) 
demonstrated no detectable P40 component, and therefore CCT could not be determined. 
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NORMAL CONTROL HD PATIENT 
FIGURE 7. 
Median nerve SEP: recording from frontal (A) and parietal (B) leads. In the normal subject 
the cortical components show a distinct pattern, while in the HD patient the cortical 
responses are markedly reduced. Cortical SEP recording after tibial nerve SEP (C); in the 
HD patient the cortical component (P40-N50-P60) is absent. 
For the median nerve SEPs, comparisons between the HD patients and the control 
subjects with Student t-tests indicated significantly reduced peak-to-peak amplitudes (PI 4-
N20 and P20-N30) (p<0.001 for each comparison). There was no significant difference as 
concerns CCT (p=0,2074) (Table 1). When the HDC subjects and the controls were compared 
with t-tests or Mann-Whitney U tests, CCT and the P14-N20 amplitude also demonstrated 
significant alterations in the HDC group (p<0.05 for each comparison). However, when the 
significance level was corrected for type 1 errors (Bonferroni), these effects were no longer 
observed. 
For the tibial nerve SEPs, we noted a more robust difference between the three groups 
(Table 1). In a majority of HD patients (9 of 11), no detectable P40-N50-P60 was present, in 
spite of a normal N22 (lumbar) component. The HDC - control difference was also larger than 
that observed for the median nerve amplitudes. To further elucidate the hypothesis that the 
tibial SEP amplitudes were more severely affected, a group (HD patients vs. carriers vs. 
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controls) by SEP type (median vs. tibial) ANOVA was performed. This analysis revealed the 
main effects of group (Rao's R (4,136)=18.28, pO.OOOl) and SEP-type (Rao's R 
(2,68)=17.06, pO.OOOl). The interaction was also significant (Rao's R (4,136)=3.82, 
p<0.01). Scheffe's post hoc tests demonstrated significant amplitude reductions in the HD 
patients (pO.OOOl) and in the HDC group (pO.Ol) in comparison with the controls. The HD 
patients had smaller amplitudes as compared with the carriers (p0.05). The tibial SEP 
amplitudes were more severely affected than the median SEP amplitudes when the HD 
patients and the controls were contrasted (Rao's R (2,68)=7.63, p0.005). However, this 
effect was observed merely as a slight tendency when the carriers and the controls were 
contrasted (p=0.16). 
Relationship between SEP parameters and CAG repeat length 
To investigate the relationship between the neurophysiological data and the genetic 
factors, Spearman's correlation coefficients were calculated between the SEP parameters and 
the number of CAG repeats measured in the HD patients (median: 45, min: 40, max: 70) and 
in the HDC group (median: 44, min: 41, max: 46). This analysis revealed that smaller 
N20/P14 and N30/P20 amplitudes were associated with a higher number of CAG repeats (R=-
0.61, p=0.012 and R=-0.56, p=0.023, respectively). All other correlation remained below the 
level of statistical significance (p>0.1). 
Effects of clinical and demographic parameters 
The duration of the illness correlated only with CCT (R=0.75, p=0.029), and not with 
other SEP parameters. It is of particular interest that we found no significant correlation 
between the age and the measured SEP parameters (p>0.1), because in this study the control 
group was younger than the patient group. For exclusion of the potentially confounding effect 
of age, only age-matched control subjects were included in a separate control analysis. The 
result remained the same, suggesting that the between-group effects were not due to age 
differences. Similarly to previously published data (Noth 1984, Bollen 1985, Abbruzzese 
1990), we obtained the same results when the medicated patients were excluded. Finally, 
there was no significant difference between the male and female participants (p>0.6). 
SEPs in focal lesions of the striatum 
In patient ST (figure 8), stimulating median nerve on the left side (contralateral to the 
striatal lesions) evoked no identifiable frontal components (P20, P22, N30) and a parietal 
component of slightly reduced amplitude (P14-N20 = 1.98 pV). Stimulating the right side 
resulted in normal cortical components (P20-N30 = 2.00 pV, P14-N20 = 2.60 pV). This 
,1 ~ .J 
< 
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patient was reexamined, using additional recording sites (C3, C4, P3, P4) too, but the frontal 
components, on the affected side were missing even in these recordings. 
FIGURE 8. MEDIAN NERVE SEPs. 
Recordings from right and left sides are shown superimposed. A: healthy control. B: a patient 
with focal striatal lesions on the righr side. Upper tracings: frontal recordings. Lower 
tracings: parietal recordings. Straight line represents the baseline. 
2. PERCEPTUAL CATEGORIZATION/DECISION PROCESS (ERPs) 
P100 and N150 
Concerning the primary occipital component (PI00), there was no significant 
difference between the control subject and HD patients (p>0.1) (Table 2.). However, the 
amplitude of N150 component was smaller for both kinds of stimuli in the HD group than in 
the control and in the HDC group. Comparing the control and the HD group, there were main 
effects of stimulus (F(l, 22)=5.63, p<0.03, 8=1.00) and electrode site (F(6, 132)=13.3, 
p<0.0001, s=0.495). The effect of group almost reached the significance level (F(l, 22)=4.05, 
p=0.056). The interactions between group and electrode site (F(6, 132)=4.604, p<0.003, 
8=0.495) were also significant. Other two-way interactions remained non-significant (group 
and stimulus: p=0.56; stimulus and electrode-site: p=0.14). The three-way interaction was 
almost significant (F(6, 132)=2.03, p=0.06, e=0.61). 
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P100 N150 N150 N150 N150 N150 N150 N150 
Amp. (SD) amp. diff. amp. diff. amp. diff. amp. diff. amp. Diff. amp. diff. amp. difl 
pV at Fz at Cz at Pz At F3 at F4 at T3 at T4 
pV pV pV pV pV pV pV 
Control 9.22±5.2 -1.67 -1.82 -1.27 -1.25 -1.58 -1.6984 -1.67 
HD 8.58±2.9 -1.25 -0.69 -0.94 -1.06 -1.14 -0.14 -0.27 
HDC 10.75±3.2 -1.33 -1.25 -1.66 -0.875 -1.29 -1.54 -1.22 
Table 2. 
Mean PI 00 amplitude and N150 amplitude differences (subtracting animal from non-animal 
ERPs) in the control, HD and HDC subjects. 
Fisher LSD tests revealed that non-animals elicited more negative responses than 
animals at each electrode site (p<0.015). Within-group comparisons indicated that these more 
negative non-animal components only were present in the control group at all electrode 
locations (p<0.0001). Conversely in the HD group the non-animal items failed to trigger a 
more negative component at the two temporal sites (T3, T4, p=0.68); at all other electrode 
sites the non-animal components were more negative than the animal components (p<0.05) 
(figure 9). 
100 m s 
FIGURE 9. GRAND AVERAGE ERPs OF THE CONTROL (a) AND THE HD 
GROUP (b) 
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In the patient with focal lesions of the striatum, the PI00 was normal. However, in 
contrast to the controls, the non-animal images failed to evoke a larger N150 than animal 
images (target-distracter N150 difference smaller than -0.5 pV) at all electrode sides. 
Comparing the control and the HDC group the three way ANOVA showed main effect 
of stimulus (F(l, 19)=17.056, p<0.0006) and electrode localization (F(6,114)=9.37, p<0.0001, 
s=0.48). The other effects and interactions remained non-significant. 
The CAG repeat length and the duration of the disease did not correlate with the 
amplitude ofN150 component (Spearmann, r=-0.10-0.56,0.05-0.3, respectively). 
3. COGNITIVE FUNCTIONS 
Neuropsychological tests 
In the case of four measures (WCST categories completed and perseverative errors, 
digit span backward, alphabet span), the performance of ST was impaired, falling outside the 
normal range (control mean +/- 1 SD). No other impairments were observed. After the steroid 
therapy, these impairments showed a marked improvement (Table 3). 
Habit-learning (PCL) 
Before treatment, a subjects (ST vs. controls vs. patients with parietal damage) by trial 
blocks analysis of variance (ANOVA) showed main effects of subjects (F(2,17)=6.34, 
p<0.01) and trial blocks (F(4,68)=4.84, p<0.002). The two-way interaction was not significant 
(p>0.5). Tukey's HSD tests indicated that both ST and the parietal patients showed lower 
overall performances in comparison with the controls (p<0.05), whereas there was no 
significant difference between ST and the parietal patients (p>0.5). However, analyses of 
linear trend indicated that both the controls (F(l,17)=30.38, pO.OOl) and the parietal patients 
(F(l,17)=24,60, pO.OOl) increased their performance as a function of trial blocks, whereas 
this effect was not present in ST before or after the treatment (p>0.21) (Figure 10). In 
addition, when ST and the parietal patients were contrasted for a linear trend, there was a 
significant interaction (F(l,17)=5.38, p<0.05). No such interaction was found when the 
parietal and the control participants were compared (p>0.5). 
After the completion of additional 50 trials, the performance of the controls was 
69.0% (SD=7.4), while that of ST was 67.5% (SD=9.6) before the treatment and 65.0% 
(SD=5.8) after the treatment. Separate t-tests showed that these data were not different from 
the control value (p>0.3), and no individual data were below the cut-off score after the 
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completion of all 100 trials. In the declarative memory test, the control mean was 89.0 % 
(SD=11.0). ST's performance was 85% before the treatment and 80% after the treatment. 
CONTROL 1 CONTROL 2 ST BEFORE 
TREATMENT 
ST AFTER 
TREATMENT 
Number of categories 
completed (WCST) 5.6(0.5) 5.8 (0.4) 3 5 
Perseverative errors 
(WCST) 6.7(1.3) 6.5 (1.4) 31 9 
Digit span forward 7.4 (0.5) 7.6 (0.7) 7 7 
Digit span backward 6.9 (0.6) 6.8 (0.6) 4 7 
Word span 6.1 (0.9) 6.1 (0.7) 6 6 
Alphabet span 5.3 (0.5) 5.2 (0.8) 3 5 
Phonological fluency 15.8(2.3) 15.9(1.7) 15 14 
Semantic fluency 20.2 (2.1) 19.9(2.8) 19 21 
Facial Recognition - - 53/54 52/54 
Object Decision - - 23/25 24/25 
Association Match - - 50/52 51/52 
Category Match - - 17/18 18/18 
Table 3. Neuropsychological performance of ST and the matched control subjects 
In the two testing sessions of the control participants (CONTROL 1 and CONTROL 2), 
Wisconsin Card Sorting Test (WCST), digit span, word span, alphabet span, and fluency tests 
results depict mean values (SD). In the case of Facial Recognition, Object Decision, 
Association Match, and Category Match tests the first number refers to the score obtained 
from ST, while the second number indicates the maximal score. Values for ST are shown 
before and after the steroid therapy 
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FIGURE lO.The performance of ST, healthy controls, and patients with parietal lobe lesions 
in the probabilistic classification learning procedure. 
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V. 
DISCUSSION 
1. PRIMARY PERCEPTION AND CORTICAL EXCITABILITY (SEPs) 
In accordance with previously published data, in HD patients we demonstrated a 
significant reduction in the early cortical component amplitudes of the median and tibial nerve 
SEPs. There has been considerable controversy concerning the explanation of such SEP 
alteration in HD, since sensory changes are not typically part of the HD symptomatology. 
Neuronal loss in the thalamus and the somatosensory cortex and the effects of medication 
were also taken into consideration. 
We observed a significant correlation between the CAG repeat length and the severity 
of the amplitude reduction of both the frontal and parietal components of the median nerve 
SEPs, with longer repeats being associated with a more pronounced decrease in amplitude. 
Post-mortem studies revealed a strong correlation between the repeat length and the severity 
of neuronal loss in the striatum (Furtado 1996). Therefore, it is highly possible that the SEP 
alterations are caused by the pathological process in the striatum, probably by affecting the 
cortical excitability through subcortical neuronal circuits passing through the basal ganglia. 
This hypothesis is supported by the results of PET studies (Kuwert 1993), showing a 
correlation between the decrease in striatal glucose consumption and the extent of SEP 
alteration, and additionally by animal models (Schwarz 1992), in which excitotoxic damage to 
the basal ganglia alone was sufficient to induce the SEP changes. 
Conflicting results have been published concerning the SEP latencies. In contrast with 
several authors (Takahashi 1972, Oepen 1981, Josiassen 1982, Abbruzzese 1990), we found 
normal CCT in the HD patients and also in the HDC group. The lack of a correlation between 
CCT and the length of the nucleotide repeat also suggests that action potential conduction is 
unaltered in HD. 
In the present study the tibial SEP was found to be more sensitive than the median 
SEP, the reduction in the tibial SEP cortical component amplitudes being the only significant 
neurophysiological change observed in the HDC group. Although this alteration has been 
described in previous reports (Noth 1984, Bollen 1985), our study demonstrated more severe 
alterations. The major methodological difference was that we used an ipsilateral auricular 
reference instead of Fz, which might account for the slightly different results. The severe 
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alterations in the cortical components of the tibial SEP in most of the HD patients (in 9 of the 
11 patients the components were absent) explains why there was no mathematically 
demonstrable correlation between the nucleotide repeat length and the tibial SEP alterations. 
This is the first study to report a relationship between the severity of 
neurophysiological abnormalities and the extent of a trinucleotide repeat extension, the 
genetic background of several inherited neurodegenerative disorders. 
In the patient with focal lesions in the right hemisphere confined to the striatum, we 
found selectively abolished frontal components and a parietal component with decreased 
amplitude, on the affected side. In contrast to patients with neurodegenerative diseases, in ST 
we had the opportunity to study the consequences of lesions limited to certain anatomic 
structures. These data further emphasize the important role of the striatum in the generation of 
the median nerve SEPs, especially in the formation of the frontal components. 
2. PERCEPTUAL CATEGORIZATION/DECISION PROCESS (ERPs) 
Using a visual categorization (animal/non-animal) task, we have found that in HD 
patients, the non-animal versus animal difference in the N150 component was only altered at 
the temporal electrode sites. In previous studies this alteration was demonstrated at all 
electrode sites in PD patients, but at none of the electrode sites in patients with Alzheimer's 
disease (Antal et al. 2002a, 2002b), where a widespread cortical pathology is well known. 
Based on these findings we attributed the alterations in the N150 component found at the 
temporal electrode sites to the pathologic changes in the basal ganglia. Of note is, that 
neuroanatomic studies (Middleton and Strick 1996) showed a closed loop connection between 
the basal ganglia and the temporal cortex, which influences higher order visual processing. 
Thus the alteration of the N150 component at the temporal electrodes might be a consequence 
of the malfunctioning in these circuits. PD and HD affect basal ganglia functions in very 
different ways: in PD the degeneration of nigro-striatal dopaminergic circuitry occurs 
beginning in the putamen, while in HD the striatum is degenerated itself (in a dorsal-to-
ventral and medial to lateral manner) starting in the caudate nucleus (Joel 2001). Although the 
striatum suffers the greatest damage, other neuronal regions are affected to varying degrees, 
such as the cortex, globus pallidus, subthalamic nucleus, amygdala, thalamus and 
hypothalamus. The substantia nigra, pars compacta, the nucleus basalis of Meynert, the dorsal 
raphe and the locus coeruleus afferent projection systems seem to be spared in contrast to PD. 
Thus, our results suggest that different degenerative processes of the basal ganglia can cause 
distinct alterations of the cortical excitability. This is further supported by similar, but not 
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identical neurophysiological changes (SEPs and ERPs) found in a patient with focal vascular 
lesions of the striatum. 
In the HD group the N150 component was diminished for both kind of stimuli. This is 
intriguing especially in the light of normal primary occipital component (PI00). We 
hypothesize that these N150 changes are related to the decreased cortical excitability due to 
the dysfunctional cortico-basal ganglia-cortical circuits. In previous studies, several authors 
reported a reduction in the PI00 amplitude (Oepen et al. 1982, Josiassen et al 1984, Hennerici 
et al. 1985). The difference between these and our findings (normal PI00) could be explained 
by the difference in the types of stimuli: checkerboard pattern reversal in the previously 
published articles versus complex natural scenes in our study. 
The lack of relationship between the changes in the categorization/decision process 
and the CAG repeat length is not surprising since it was shown that cognitive symptoms are 
unrelated to the repeat length (Ross et al. 2001) but our sample was too small for a definite 
conclusion about this aspect. 
Asymptomatic HDC mutation carriers in this ERPs study were not different from 
control subjects concerning the N150 component. However the number of subject in this 
group was too small to draw a conclusion. Repeated measurements in a larger population may 
help us to clarify this aspect. 
This is the first study that described in HD patients, a neurophysiological evidence for 
impairment of the early perceptual processes in a visual categorization/decision task. We have 
found that although HD and PD are widely used models of basal ganglia dysfunction in 
humans, HD subjects showed a different pattern of impairment from what was observed in PD 
patients. 
Defining specific neurophysiological alterations corresponding to distinct pathologic 
changes in the basal ganglia may consistently help us to a better understanding of the normal 
and abnormal functioning of the affected neural circuits. 
3. COGNITIVE FUNCTIONS 
Neuropsychological examination of ST revealed selective impairments in attentional 
set-shifting (WCST perseverative errors), digit span backward, alphabet span, and habit 
learning (PCL). By contrast, general intellectual functions, short-term memory for digits and 
words, verbal fluency, episodic and semantic memory, and object recognition, were 
unaffected. After steroid therapy, attentional set-shifting and related functions showed robust/ 
/ V 
improvement (probably due to an increase in blood flow in the compromised vessels), 
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whereas habit learning remained severely impaired. The alteration of attentional set-shifting 
and related functions cannot be attributed solely to basal ganglia pathology, since they 
improved after the steroid therapy in spite of the definite (irreversible) nature of the striatal 
lesions (as shown by repeated MRI). However, the alteration in habit learning (PCL) might 
indeed be the consequence of striatal lesions, since it remained unchanged after the therapy. 
PCL impairment cannot be explained by the parietal lesions, because the patients with 
damaged parietal lobes showed normal learning rates in the PCL task. It is unlikely that the 
therapy led merely to a global improvement, because attentional set-shifting is more difficult 
than the PCL-type tasks for normal participants (Roberts et al. 1998). 
In the early phase of PCL (1-50 trials) there was an obvious deficit in habit learning, 
whereas episodic memory for cues and experimental circumstances was spared. In later 
phases of the PCL (50-100 trials) ST's performance increased, which suggests that he used the 
spared explicit memory functions to encode stimulus-response patterns similarly to patients 
with Parkinson's disease (Knowlton et al., 1996). While executive functions robustly 
improved after the steroid therapy, ST was still unable to learn stimulus-response habits. 
Overall, these data support previous observations from patients with amnesia, Parkinson's 
disease, and frontal lobe lesions (Knowlton et al. 1994, 1996), suggesting that executive 
(attentional set-shifting) dysfunction can be independent of habit learning problems, although 
dual deficits often occur. In addition to the neuropsychological evidence, a number of studies 
using animal models indicated that set-shifting and reversal learning are mediated by separate 
neuronal systems. Set-shifting is related to the dorsal ffonto-striatal system, whereas reversal 
learning is related to ventral ffonto-striatal circuits (Divac et al. 1967, Jones and Mishkin 
1972, Dias et al. 1996, Li and Shao 1998, Ferry et al. 2000). 
In connection with our interpretation, two important limitations must be mentioned. 
The lesions were restricted to the basal ganglia, only in one hemisphere, which raises the 
possibility that lesions outside these structures in the other hemisphere may have contributed 
to his dysfunctional performance. We tried to exclude this possibility by the assessment of 
patients with parietal damage and found that these patients showed normal learning rates in 
the PCL task. The possible role of the left medial thalamic infarct was not specifically 
investigated. Although this lesion was small, it is possible that it may have induced a 
disconnection in the left fronto-striato-thalamo-cortical circuits, specifically contributing to 
the set-shifting and habit learning anomalies. It must be also taken into consideration that 
vasculitis potentially results in brain dysfunction not detected by MRI. However, the presence 
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of a diffuse cerebral lesion with a generalised cognitive impairment was clearly excluded, 
since ST's impairment was selective for a subset of neuropsychological tests. 
4. MANY INTERCONNECTED CIRCUITS 
Although the basal ganglia have long been viewed as playing a central role in motor 
control, there is increasing evidence, that these structures are essential for synchronisation of 
neural circuits related to many other functions of the brain. This is not surprising, given the 
fact, that the basal ganglia receive inputs from all cortical areas, and in turn, affect the 
cerebral cortex via their thalamic projections. 
In the last 16 years, the most dominant view of the cortico-basal ganglia-thalamo-cortical 
circuits was the one pioneered by Alexander et al. According to this, the circuits are organised 
in a parallel manner and remain structurally and functionally segregated from one another 
(Alexander at al. 1986). They identified five parallel circuits: motor, oculomotor, dorsolateral 
prefrontal, lateral orbitofrontal and limbic / anterior cingulate. 
Our results showed, that damage to the basal ganglia was associated with alteration of a 
wide spectrum of CNS functions: perception, categorization, decision, and implicit learning, 
further emphasizing the central role of the basal ganglia as a substrate for synchronization of 
different neural activities. 
According to the theory of the segregated parallel circuits, our findings would imply that 
all basal ganglia structures involved in the affected circuits were damaged. However, there is 
mounting evidence that these "parallel" circuits are interconnected both structurally and 
functionally (Joel 2001). This means that pathology of selected, strategically essential 
components have consequences in several functional domains. We consider that our findings 
are in consistence with this view of the basal ganglia functioning within a system of 
interconnected parallel circuits. 
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CONCLUSIONS 
1. Damage of the striatum causes decreased cortical excitability, as shown by reduced 
amplitudes of the SEP and ERP amplitudes in HD and in focal lesions of the striatum. 
2. The amplitude reduction of the median nerve SEPs in HD is proportional to the extent of 
the genetic mutation i.e. the length of the trinucleotide repeat. 
3. Tibial nerve SEPs is a sensitive method to detect early pathophysiological changes in HD, 
being the only neurophysiological alteration in asymptomatic carriers of the mutation, in 
our studies. 
4. Focal lesions of the striatum can differentially affect the cortical components of the 
median nerve SEPs, with more severe alteration of the frontal than the parietal 
components. 
5. Perceptual categorization/decision process shows a specific pattern of alteration in HD, 
with consequence at the temporal recording sites, according to visual categorization-task 
ERPs. This was different from the ERP changes found in focal vascular lesions of the 
striatum and in PD. 
6. Focal lesions of the striatum cause impairment in habit-learning (PCL). 
7. Executive dysfunction (attentional set-shifting) can be independent of habit learning 
problems. 
Taken together, these data suggest, that striatum plays a crucial role in the organisation of 
such distinct CNS functions as primary perception, perceptual categorisation/decision and 
habit learning. Thus clinical consequences of striatal damage must be thought off as a 
summation of these, multilevel malfunctions. 
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